|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/395 | (2006.01) |
| A61K 31/535 | (2006.01) | ||
| A61K 31/536 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3347006 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16769437.1 |
| Date of filing the European patent application | 2016-03-18 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-27 |
| (46) | Date of publication of the claims translation | 2022-10-25 |
| (86) | Number | PCT/US2016/023231 |
| Date | 2016-03-18 |
| (87) | Number | WO 2016/154039 |
| Date | 2016-09-29 |
| (30) | Number | Date | Country code |
| 201562135979 P | 2015-03-20 | US |
| (72) |
DASSE, Olivier , US
|
| (73) |
GABA Therapeutics Inc. ,
5000 Birch Street
West Tower, Suite 3000, Newport Beach, CA 92660,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Deuterinti etifoksino analogai, jų dariniai ir panaudojimai |
| DEUTERATED ANALOGS OF ETIFOXINE, THEIR DERIVATIVES AND USES THEROF |
| Payment date | Validity (years) | Amount | |
| 2025-02-21 | 10 | 231.00 EUR |
| 2026-03-18 |